Vection Technologies (ASX:VR1) has received $1.2 million in cash from government R&D programs, disclosed as non-repayable and non-dilutive funding, to support development across four technology domains including Artificial Intelligence, Extended Reality, Digital Health, and Inclusive AI products.
Key Points
- $1.2 million in non-repayable, non-dilutive government funding confirmed across four active R&D grant programs
- Funds to be applied within the company's existing product roadmap across four targeted innovation projects and to improve working capital position
- The four programs cover Inclusive AI and Sign Language translation (L4ALL), Cultural and Museum AI (URGO ISI), Immersive Heritage Visualisation (AVATART Calabria), and AI-powered Digital Health Rehabilitation (OMNIREHAB)
- Research partnerships include University College London, the National Research Council of Italy, the University of Milano-Bicocca, the University of Calabria, and Università Telematica Internazionale Uninettuno
Four R&D Program Details
The four distinct programs each address a separate technology domain. L4ALL focuses on next-generation AI for automatic translation of multimedia content into Sign Language via Vection's Text-to-LIS platform, with partners including CNR LACAM and Università Uninettuno. URGO ISI develops an adaptive conversational AI platform for museums in partnership with University College London and the University of Milano-Bicocca. AVATART Calabria delivers immersive cultural heritage experiences using AI-powered 3D avatars and holographic visualisation technologies alongside the University of Calabria. OMNIREHAB, for which Vection acts as project coordinator, is an AI-powered remote rehabilitation platform combining Motion Capture and Extended Reality for home-based rehabilitation, partnering with two healthcare cooperatives operating in Tuscany.
Alignment with Core Product Platforms
According to the filing, the programs are aligned with Vection's core product platforms: Algho AI, described as conversational and multimodal AI; INTEGRATEDXR®, described as immersive reality; and Vection's accessibility and phygital hardware capabilities. The filing states that technologies and capabilities developed through these programs will be integrated into Algho AI and INTEGRATEDXR®, while other activities are described as generating standalone intellectual property. The funding was awarded based on the achievement of independently evaluated milestones and on criteria reflecting a high level of innovation capability in the development of AI and Extended Reality technologies, the filing states.
Managing Director Statement on Funding and Business Position
Managing Director and Executive Chairman Gianmarco Biagi said in the filing that achieving the milestones leading to the funding confirmation demonstrates the value of Vection's development capabilities and confirms the work meets independently assessed standards, including at an international level. Biagi also stated that Vection enters FY27 as a commercially self-sustaining business with positive operating cash flow and a very large sales pipeline, and that the R&D programs are advanced through a combination of Vection's own investment and government funding. The filing was authorised by the Board of Directors of Vection Technologies Limited and is dated 10 August 2026.
_11_19_2026_18_26_10_400840.jpg)




Please wait processing your request...